Home

Daniel J Starck

CIK 1345856 · EVP, Business Excellence · last filed 2024-05-16

Daniel J Starck is an EVP, Business Excellence who has filed 51 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for ACH, was dated Jul 23, 2024. Across all open-market trades the lifetime net is −$4.3M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

51

Lifetime Open-Market Net

-$4.34M

Filer Profile

Reported Address
CORVEL CORPORATION
2010 MAIN STREET, SUITE 600
IRVINE, CA 92614
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ACCENDRA HEALTH INC/VA/ (OMI) Delisted EVP, Business Excellence 95,612 $2.80 $267.8K $0 5 2024-05-16
Apria, Inc. (APR) Delisted Chief Executive Officer 0 $37.50 $0 $0 2 2022-03-29
CORVEL CORP (CRVLE) Delisted CEO/PRESIDENT/COO 25,768 — — -$4.34M 38 2012-02-17

Recent Filings

51 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-07-23 ACH Notice (144) −23,183 -$389.3K EDGAR
2024-05-16 ACCENDRA HEALTH INC/VA/ (OMI) Delisted Tax (F) −9,446 -$186.8K EDGAR
2024-03-05 ACCENDRA HEALTH INC/VA/ (OMI) Delisted Grant (A) +32,975 $0 EDGAR
2023-05-17 ACCENDRA HEALTH INC/VA/ (OMI) Delisted Tax (F) −2,139 -$40.1K EDGAR
2023-03-03 ACCENDRA HEALTH INC/VA/ (OMI) Delisted Grant (A) +52,624 $0 EDGAR
2022-05-11 ACCENDRA HEALTH INC/VA/ (OMI) Delisted Grant (A) +21,598 $0 EDGAR
2022-03-29 Apria, Inc. (APR) Delisted Mixed −220,448 -$8.27M EDGAR
2022-03-16 Apria, Inc. (APR) Delisted Mixed +10,022 -$301.3K EDGAR
2021-08-24 — Sell (S) −25,983 -$934.2K
2021-08-20 — Sell (S) −52,762 -$1.86M
Showing 1–10 of 51
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.